Suchergebnisse - "Markowski, Mark C"

PubPharm (71)

21

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Markowski, M. | Tutrone, R. | Pieczonka, C. | +7

22

Bipolar androgen therapy (BAT) : A patient's guide

enthalten in: The Prostate | 2022

von Denmeade, S. | Antonarakis, E. | Markowski, M.

23

Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy

enthalten in: Clinical genitourinary cancer | 2022

von Markowski, M. | Kachhap, S. | De Marzo, A. | +4

24

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer : Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL

enthalten in: Molecular imaging | 2022

von Werner, R. | Habacha, B. | Lütje, S. | +19

25

Bipolar androgen therapy (BAT) : A patient's guide

enthalten in: The Prostate | 2022

von Denmeade, S. | Antonarakis, E. | Markowski, M.

26

The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2022

von Dong, L. | Su, Y. | Zhu, Y. | +10

27

The interplay of microbiota and hormone regulation in men with prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2021

von Markowski, M. | Sfanos, K.

CommentOn: Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1063-1072. - PMID 33850270

28

Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

enthalten in: Cancer research | 2021

von Kumar, R. | Mendonca, J. | Owoyemi, O. | +22

CommentIn: Nat Rev Urol. 2021 Dec;18(12):706. - PMID 34741154

29

Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2021

von Zukotynski, K. | Emmenegger, U. | Hotte, S. | +16

30

Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2021

von Markowski, M. | Velho, P. | Eisenberger, M. | +6